GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » E10

Syngene International (BOM:539268) E10 : ₹11.91 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Syngene International's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹4.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹11.91 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Syngene International's average E10 Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-01), Syngene International's current stock price is ₹688.95. Syngene International's E10 for the quarter that ended in Mar. 2024 was ₹11.91. Syngene International's Shiller PE Ratio of today is 57.85.

During the past 13 years, the highest Shiller PE Ratio of Syngene International was 72.86. The lowest was 52.52. And the median was 62.62.


Syngene International E10 Historical Data

The historical data trend for Syngene International's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International E10 Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 11.32 11.91

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.32 11.52 11.61 11.73 11.91

Competitive Comparison of Syngene International's E10

For the Biotechnology subindustry, Syngene International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Syngene International's Shiller PE Ratio falls into.



Syngene International E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngene International's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.7/153.2548*153.2548
=4.700

Current CPI (Mar. 2024) = 153.2548.

Syngene International Quarterly Data

per share eps CPI Adj_EPS
201403 7.001 91.425 11.736
201409 1.030 96.780 1.631
201412 1.120 96.780 1.774
201503 1.395 97.163 2.200
201506 1.180 99.841 1.811
201509 1.225 101.753 1.845
201512 1.690 102.901 2.517
201603 2.000 102.518 2.990
201606 1.515 105.961 2.191
201609 1.885 105.961 2.726
201612 1.880 105.196 2.739
201703 1.975 105.196 2.877
201706 1.565 107.109 2.239
201709 1.935 109.021 2.720
201712 2.065 109.404 2.893
201803 2.125 109.786 2.966
201806 1.660 111.317 2.285
201809 1.970 115.142 2.622
201812 2.190 115.142 2.915
201903 2.520 118.202 3.267
201906 1.460 120.880 1.851
201909 3.220 123.175 4.006
201912 2.310 126.235 2.804
202003 3.020 124.705 3.711
202006 1.460 127.000 1.762
202009 2.100 130.118 2.473
202012 2.550 130.889 2.986
202103 4.010 131.771 4.664
202106 1.890 134.084 2.160
202109 1.630 135.847 1.839
202112 2.550 138.161 2.829
202203 3.740 138.822 4.129
202206 1.830 142.347 1.970
202209 2.530 144.661 2.680
202212 2.710 145.763 2.849
202303 4.450 146.865 4.644
202306 2.320 150.280 2.366
202309 2.900 151.492 2.934
202312 2.770 153.255 2.770
202403 4.700 153.255 4.700

Add all the adjusted EPS together and divide 10 will get our e10.


Syngene International  (BOM:539268) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Syngene International's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=688.95/11.91
=57.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Syngene International was 72.86. The lowest was 52.52. And the median was 62.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Syngene International E10 Related Terms

Thank you for viewing the detailed overview of Syngene International's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (BOM:539268) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines